OABI
OABI
NASDAQ · Life Sciences Tools & Services

Omniab Inc

$3.96
+0.14 (+3.66%)
As of Aug 18, 1:55 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +38.4% upside
Low Target $3.95
Average Target $5.48
High Target $7.31
Current Price $3.96
Current
$3.96
Target
$5.48
$3.95 $5.48 avg $7.31
Scenario Analysis
Bear Case
$3.95
-0.3%
Low target
Base Case
$5.48
+38.4%
Avg target
Bull Case
$7.31
+84.6%
High target
Risk/Reward
335.0x
Highly favorable
Price in Context
52-Week High
$3.64
8.9% from high
52-Week Low
$1.30
+204.6% from low
Target vs 52W High
$5.48
+50.8% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 36 81% $369.21 -37.3%
DHR
Danaher Corp
Strong Buy 32 84% $158.11 -20.8%
A
Agilent Technologies Inc
Strong Buy 29 76% $64.69 -56.4%
WAT
Waters Corp
Hold 31 55% $189.60 -52.7%
IQV
Iqvia Holdings Inc
Strong Buy 28 79% $82.96 -65.4%
ILMN
Illumina Inc
Buy 28 61% $169.36 -10.1%
MTD
Mettler-Toledo International
Hold 19 47% $170.43 -87.8%
WST
West Pharmaceutical Services
Strong Buy 23 91% $136.24 -60.7%